Why the study?
Does losartan alter plasma active and inactive renin and active renin glycoforms in essential hypertensive patients?
Population
11 essential hypertensive patients
Comparison
Losartan 50 mg single dose and monotherapy for… vs Pretreatment baseline
Design
Cohort
Follow-up
42 days
Authors
Loading...
No immediate change to losartan use in hypertension; leaves open clinical relevance of renin glycoform shifts.
Does losartan alter plasma active and inactive renin and active renin glycoforms in essential hypertensive patients?
Acute and chronic losartan therapy increases circulating active renin concentration and alters the profile of circulating renin glycoforms in essential hypertensive patients.
Opsahl et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: